Table 2. Comparison of pre- and post-treatment values within the groups and between the groups.
Study group (n=21) | Control group (n=20) | p | |||
Median | Min-Max | Median | Min-Max | ||
BFMF pre-treatment | 3 | 2-4 | 2,5 | 2-4 | 0,236 |
BFMF post-treatment | 2 | 1-3 | 2,5 | 2-4 | 0.001* |
p | <0.001* | 0,317 | |||
GMFCS pre-treatment | 3 | 2-4 | 3 | 2-4 | 0,434 |
GMFCS post-treatment | 3 | 2-4 | 3 | 2-4 | 0,673 |
p | 0.005* | 0,157 | |||
FMS pre-treatment | 2 | 1-5 | 3 | 1-5 | 0,395 |
FMS post-treatment | 2,5 | 1-5 | 3 | 1-5 | 0,676 |
p | 0.002* | 0,336 | |||
Min-Minimum; Max: Maximum; BFMF: Bimanual fine motor function; GMFCS: Gross motor function classification system levels; FMS: Functional mobility scale; Wilcoxon test was used for intragroup analysis and Mann Whitney U test was used for intergroup analysis (shown in bold); * p<0.05 was assumed to be significant. |